Biblio

Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2024
Guerineau H, Kohn M, Hamoud AAl, Sellier J, Osman J, Cabannes-Hamy A. Could it be VEXAS?. Ann Hematol. 2024.
Ferreira LGA, Kizys MML, Gama GAC, Pachernegg S, Robevska G, Sinclair AH, Ayers KL, Dias-da-Silva MR. COUP-TFII regulates early bipotential gonad signaling and commitment to ovarian progenitors. Cell Biosci. 2024;14(1):3.
Sliman YA, Samoylenkova NS, Antipova OM, Brylev VA, Veryutin DA, Sapozhnikova KA, Alekseeva AI, Pronin IN, Kopylov AM, Pavlova GV. [Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells]. Zh Vopr Neirokhir Im N N Burdenko. 2024;88(1):48-55.
Dall'Olio D, Sträng E, Turki AT, Tettero JM, Barbus M, Schulze-Rath R, Elicegui JMartinez, Matteuzzi T, Merlotti A, Carota L, et al. Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology. PLoS Comput Biol. 2024;20(2):e1011299.
Nakamura N, Tsunemine H, Ikunari R, Sakai T, Arima N. COVID-19 antibody titers after tixagevimab-cilgavimab injection in patients with hematologic diseases; a single-center, prospective study. Leuk Lymphoma. 2024:1-10.
Randi BAzevedo, Higashino HRyoiti, da Silva VPonzio, Salomão MChiarastel, Pignatari ACarlos Cam, Abdala E, Vasques F, da Silva CArrais Rod, da Silva RLuiz, Lazari CDos Santos, et al. COVID-19 in hematopoietic stem cell transplant recipients during three years of the pandemic: a multicenter study in Brazil. Rev Inst Med Trop Sao Paulo. 2024;66:e17.
Zhang Z, Huang J, Wang L, Pan Z, Huang J, Jiang C, Zhang S, Li S, Hu X. COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study. Blood Sci. 2024;6(2):e00183.
A VAN Voorden J, DE Groot CJM, Ris-Stalpers C, Afink GB, VAN Leeuwen E. COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development. Int J Infect Dis. 2024.
Malherbe JAJ, Boan P, Purtill D, Wright M, Cannell P, Gangatharan SA, Sidiqi H, Cooney J. COVID-19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy. Intern Med J. 2024.
Randi BA, Guimarães T, Spadao Fde S, Higashino HR, Lazari CDos S, Xavier EM, Rocha V, Costa SF. COVID-19 surveillance in a bone marrow transplantation unit: experience from a Brazilian tertiary-care teaching hospital. Support Care Cancer. 2024;32(4):271.
McDonnell J, Cousins K, M Younger EM, Lane A, Abolhassani H, Abraham RS, Al-Tamemi S, Aldave-Becerra JCarlos, Al-Faris EHesham, Alfaro-Murillo A, et al. COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. J Clin Immunol. 2024;44(4):86.
Fattizzo B, Röth A, Broome CM, Khan U, Wardęcki M, Cordoba M, Barcellini W. COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab. Am J Hematol. 2024.
Gyimesi M, Oikari LE, Yu C, Sutherland HG, Nyholt DR, Griffiths LR, van Wijnen AJ, Okolicsanyi RK, Haupt LM. CpG methylation changes in human mesenchymal and neural stem cells in response to in vitro niche modifications. Biochimie. 2024.
Renga G, Nunzi E, Stincardini C, Pariano M, Puccetti M, Pieraccini G, Di Serio C, Fraziano M, Poerio N, Oikonomou V, et al. CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis. Blood. 2024.
Wei L-N. CRABP1-mediated non-canonical retinoic acid signaling in motor neurons and neural stem cells. Neural Regen Res. 2024;19(6):1169-1170.
Raza SShadab. Creating a Reproducible Model of Spinal Cord Injury in Rats: A Contusion Approach. Methods Mol Biol. 2024;2761:559-567.
Kim H-J, Jeon H-M, Batara DCarlo, Lee S, Lee SJun, Yin J, Park S-I, Park M, Seo JBae, Hwang J, et al. CREB5 promotes the proliferation and self-renewal ability of glioma stem cells. Cell Death Discov. 2024;10(1):103.
Pérez-García I, Pérez-García V. CRISPR Activation in Mouse Trophoblast Stem Cells. Methods Mol Biol. 2024;2781:93-103.
Ghahremani S, Kanwal A, Pettinato A, Ladha F, Legere N, Thakar K, Zhu Y, Tjong H, Wilderman A, W Stump T, et al. CRISPR Activation Reverses Haploinsufficiency and Functional Deficits Caused by Truncation Variants. Circulation. 2024.
Khoshandam M, Soltaninejad H, Hamidieh AAli, Hosseinkhani S. CRISPR, CAR-T, and NK: Current applications and future perspectives. Genes Dis. 2024;11(4):101121.
Moradi Z, Kazemi M, Jamshidi-Khalifelou R, Bahramnia V, Esfandmaz F, Rahnavard R, Moradgholi B, Piri-Gharaghie T. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell. Funct Integr Genomics. 2024;24(2):61.
Nolan ND, Cui X, Robbings BM, Demirkol A, Pandey K, Wu W-H, Hu HF, Jenny LA, Lin C-S, Hass DT, et al. CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa. Cell Rep Med. 2024:101459.
Chang Y, Lan F, Zhang Y, Ma S. Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling. Stem Cell Rev Rep. 2024.
Wen B, Li E, Wang G, Kalin TR, Gao D, Lu P, Kalin TV, Kalinichenko VV. CRISPR/Cas9 Genome Editing Allows Generation of the Mouse Lung in a Rat. Am J Respir Crit Care Med. 2024.
Saifullah M, Laghzaoui O, Ozyahyalar H, Irfan A. The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review. Eur Rev Med Pharmacol Sci. 2024;28(6):2430-2463.

Pages